Modal

2024 CLARITY Program     continue reading →

CLARITY

Brain Health Assessment and Improvement Program

Cognitive decline and delirium is an all too common post-operative outcome for patients over 65 that lead to serious short- and long-term complications.

We present a proprietary suite of tools and services guided by experienced consultants. Our solution has been shown to improve patient outcomes and reduce length of hospital stay for patients with cognitive impairment.

Discover More Let's Talk – Request a Demo
prolira-delirium-qi-program

A Tech-enabled QI Program

A novel detection method along with an education and awareness program. Our program has shown to reduce the impact of outlier patients and offer hospital’s a significant return on their investment.

program-1
Better detection

Enabled through DeltaScan tech

program-2
Awareness and education

Out-of-the-box campaigns

program-3
Compliance and Outcomes

Reports, dashboards and review meetings

program-4
ROI analysis

Revenue benefit and LOS cost reduction

Program

Prolira presents a proprietary suite of tools and services guided by experienced consultants. Our solution has been shown to improve patient outcomes and reduce length of hospital stay for patients with cognitive impairment.

Our unique approach to improved management utilizes a novel new detection device that provides an objective bio-signal as the trigger for interventions. Our team works with you to educate staff, implement a dashboard to demonstrate benefit and an attractive ROI for your hospital.

DeltaScan® Brain State Monitor

DeltaScan® Brain State Monitor provides a quick and objective measurement of acute encephalopathy and delirium with high diagnostic performance to support timely interventions.

 

“Up to 88% of delirious patients go undetected in daily care practice ¹”

Marcantonio, 2017, The New England Journal of Medicine

 

Acute Brain Failure | Delirium

The Most Common Post-op Complication in Older Adults

Each year, approximately 50% of surgical and ICU patients in the US and Europe are at risk of developing acute brain failure and delirium².

Annual health system and societal costs are estimated at €320B in the U.S. and EU, rivaling costs associated with heart disease and diabetes³.

Lets get in touch!

Interested? Lets get in touch!

Discover how we help hospitals reshape care delivery for patients over 65, aiming to improve patient outcomes and deliver an attractive ROI based on reimbursement and cost reduction.

sources: ¹ Marcantonio, et al. N Engl J Med 2017 ² American Geriatric Society ³ Inouye et al. 2014 

pageversion: 1.0